🔎 Trials Near Me

Beranda › Kanker Kolon › Washington › Seattle

Uji klinis Kanker Kolon di Seattle, WA

12 studi untuk Kanker Kolon mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Menerima pesertaSukarelawan sehat diterima
  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07283939

Family Communications After Genetic Testing

Menerima pesertaSukarelawan sehat diterima
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07143487

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Menerima pesertaFase 3
  • Fred Hutchinson Cancer Center ( Site 0076), Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06997497

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • Swedish Medical Center, Seattle
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07222800

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Menerima peserta
  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi jauhnya
Usia 45 hingga 70 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Menerima pesertaFase 2/3
  • Virginia Mason Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • dan 3 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05174169

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Menerima pesertaFase 1
  • Xencor Investigative Site, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT05433142

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Menerima pesertaFase 1/2
  • Fred Hutchinson Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06051695

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Menerima pesertaFase 1/2
  • Virginia Mason Medical Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Menerima pesertaStudi observasional
  • University of Washington, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT00843375

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Seattle
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Menerima pesertaFase 1/2
  • Fred Hutch Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT06682793

Uji klinis Kanker Kolon di kota lain

Studi lain di Seattle

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.